Tag: Bristol-Myers Squibb

Pharmaceutical giant Bristol-Myers Squibb finds itself navigating complex challenges as its stock continues to face downward pressure despite demonstrating operational ...

Pharmaceutical giant Bristol-Myers Squibb has demonstrated a remarkable turnaround, with its latest quarterly report exceeding investor expectations through unexpectedly robust ...

Pharmaceutical giant Bristol-Myers Squibb faces a critical transition period as it races to offset substantial revenue declines expected from key ...

Pharmaceutical giant Bristol-Myers Squibb is making a substantial $1.5 billion strategic move to acquire biotechnology firm Orbital Therapeutics, signaling a ...

Bristol-Myers Squibb has secured a significant regulatory milestone for its Alzheimer's drug candidate BMS-986446, receiving Fast Track designation from the ...

Bristol-Myers Squibb, a major player in the biotechnology sector, currently faces a complex set of challenges and opportunities. The company's ...

Bristol-Myers Squibb has secured a significant regulatory achievement with the FDA granting Fast-Track status to its Alzheimer's disease candidate, BMS-986446. ...

Pharmaceutical giant Bristol-Myers Squibb is navigating turbulent waters as it implements an unconventional approach to maintain its market position. With ...

Pharmaceutical giant Bristol-Myers Squibb is undergoing a significant strategic transformation, marked by two major developments in key international markets this ...